Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. In the United ...

Parkinson's is a brain condition which is responsible for uncontrolled movements. It causes difficulty in talking, walking, ...

Hearing impairment has emerged as a potential risk factor for Parkinson’s disease, a progressive neurodegenerative disorder that primarily manifests with motor impairments like tremors, rigidity, and ...

Parkinson’s disease, characterized by progressive dopamine neuron loss, leads to motor deficits such as bradykinesia and rigidity, as well as nonmotor symptoms like cognitive decline and depression.

Yulan Xiong, associate professor of neuroscience at UConn Health, and her team have discovered one more piece of the puzzle ...

Innovative treatment for Parkinson's disease: microscopic particles combined with light therapy offer a non-surgical solution ...

Recent research has found that older individuals with a higher intake of caffeinated coffee, particularly the unsweetened ...

David Jilbert's devastating diagnosis of Parkinson's disease three years ago changed his life irrevocably -- and it's a ...

Parkinson’s disease is a progressive disorder of the nervous system that affects body movement. It progresses gradually and usually starts with no symptoms or barely noticeable ones in either hand.